XSES
M15
Market cap8mUSD
Jul 15, Last price
0.02SGD
Name
Matex International Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Matex International Limited, headquartered in Singapore since its establishment in 1989, specializes in the development, production, and distribution of a diverse range of specialized chemical compounds. The company's operations extend across Singapore, the People's Republic of China, and Malaysia. Its extensive product line features dyestuffs, chemical auxiliaries, textile processing chemicals, and optical brighteners, complemented by offerings in color measurement and advanced computer-aided systems. Beyond its core chemical business, Matex is also involved in the import, export, and wholesale trade of garments, various textile goods, and chemical products, alongside broader general wholesale operations. Additionally, it undertakes the manufacturing and servicing of measuring instruments, process control apparatus, and associated items. The company primarily caters to clients in the textile, paper, leather, detergent, and polymer sectors.
Key people
Chong Huat Tan
Non-Executive Independent Chairman of the Board · since 2025
Hongbo Chen
Chief Executive Officer · since 2025
Prabhakar Nithila
Chief Technical Officer · since 2006
Jiang Ma
General Manager
Shen Liu
Chief Technical Officer, Executive Director · since 2025
Guan Liang Tan
Executive Director · since 2010
Pang Kee Tan
Chief Executive Officer, Managing Director, Executive Director
Pang Sim Tan
Director/General Manager - Unimatex Sdn Bhd · since 2000
Hui Yee Cheok
Company Secretary · since 2024
Non-Executive Director · since 2023
Non-Executive Independent Chairman of the Board · since 2024
Non-Executive Independent Director · since 2025
Shaohai Fu
Non-Executive Independent Director · since 2026
Wah Ko Chung
Non-Executive Independent Director · since 2025
IPO date
Feb 18, 2004
Employees
Domiciled in
SG
Incorporated in
SG
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||